First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer
双特异性CD47抑制剂和CD40激动剂Fc融合蛋白SL-172154在铂耐药卵巢癌患者中的首次人体I期临床试验
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2024-010565
Lakhani, Nehal J; Stewart, Daphne; Richardson, Debra L; Dockery, Lauren E; Van Le, Linda; Call, Justin; Rangwala, Fatima; Wang, Guanfang; Ma, Bo; Metenou, Simon; Huguet, Jade; Offman, Elliot; Pandite, Lini; Hamilton, Erika